These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

498 related articles for article (PubMed ID: 33057172)

  • 1. Spinal muscular atrophy - insights and challenges in the treatment era.
    Mercuri E; Pera MC; Scoto M; Finkel R; Muntoni F
    Nat Rev Neurol; 2020 Dec; 16(12):706-715. PubMed ID: 33057172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New and Developing Therapies in Spinal Muscular Atrophy: From Genotype to Phenotype to Treatment and Where Do We Stand?
    Chen TH
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32392694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene Therapy for Spinal Muscular Atrophy: An Emerging Treatment Option for a Devastating Disease.
    Rao VK; Kapp D; Schroth M
    J Manag Care Spec Pharm; 2018 Dec; 24(12-a Suppl):S3-S16. PubMed ID: 30582825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Quantitative analysis of the genes determining spinal muscular atrophy].
    Nagymihály M; Herczegfalvi A; Tímár L; Karcagi V
    Ideggyogy Sz; 2009 Nov; 62(11-12):390-7. PubMed ID: 20025129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular therapeutic strategies for spinal muscular atrophies: current and future clinical trials.
    Zanetta C; Nizzardo M; Simone C; Monguzzi E; Bresolin N; Comi GP; Corti S
    Clin Ther; 2014 Jan; 36(1):128-40. PubMed ID: 24360800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spinal Muscular Atrophy and Common Therapeutic Advances.
    Bozorg Qomi S; Asghari A; Salmaninejad A; Mojarrad M
    Fetal Pediatr Pathol; 2019 Jun; 38(3):226-238. PubMed ID: 31060440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spinal muscular atrophy: diagnosis and management in a new therapeutic era.
    Arnold WD; Kassar D; Kissel JT
    Muscle Nerve; 2015 Feb; 51(2):157-67. PubMed ID: 25346245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spinal muscular atrophy: recent advances and future prospects.
    Nicole S; Diaz CC; Frugier T; Melki J
    Muscle Nerve; 2002 Jul; 26(1):4-13. PubMed ID: 12115944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between the SMN2 gene copy number and clinical characteristics of patients with spinal muscular atrophy with homozygous deletion of exon 7 of the SMN1 gene.
    Zarkov M; Stojadinović A; Sekulić S; Barjaktarović I; Perić S; Keković G; Drasković B; Stević Z
    Vojnosanit Pregl; 2015 Oct; 72(10):859-63. PubMed ID: 26665550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. c.835-5T>G Variant in SMN1 Gene Causes Transcript Exclusion of Exon 7 and Spinal Muscular Atrophy.
    Wu S; Li YL; Cheng NY; Wang C; Dong EL; Lu YQ; Li JJ; Guo XX; Lin X; Lai LL; Liu ZW; Wang N; Chen WJ
    J Mol Neurosci; 2018 Jun; 65(2):196-202. PubMed ID: 29799103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ZPR1 prevents R-loop accumulation, upregulates SMN2 expression and rescues spinal muscular atrophy.
    Kannan A; Jiang X; He L; Ahmad S; Gangwani L
    Brain; 2020 Jan; 143(1):69-93. PubMed ID: 31828288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disease mechanisms and therapeutic approaches in spinal muscular atrophy.
    Tisdale S; Pellizzoni L
    J Neurosci; 2015 Jun; 35(23):8691-700. PubMed ID: 26063904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic Variability in the Survival Motor Neuron Genes (
    Butchbach MER
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [SMN1 Gene Point Mutations in Type I-IV Proximal Spinal Muscular Atrophy Patients with a Single Copy of SMN1].
    Genetika; 2015 Sep; 51(9):1075-82. PubMed ID: 26606804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spinal muscular atrophy: mechanisms and therapeutic strategies.
    Lorson CL; Rindt H; Shababi M
    Hum Mol Genet; 2010 Apr; 19(R1):R111-8. PubMed ID: 20392710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Spinal muscular atrophy - clinical spectrum and therapy].
    Walter MC; Stauber AJ
    Fortschr Neurol Psychiatr; 2018 Sep; 86(9):543-550. PubMed ID: 30248687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perspectives in genetic counseling for spinal muscular atrophy in the new therapeutic era: early pre-symptomatic intervention and test in minors.
    Serra-Juhe C; Tizzano EF
    Eur J Hum Genet; 2019 Dec; 27(12):1774-1782. PubMed ID: 31053787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adult-onset spinal muscular atrophy: An update.
    Juntas Morales R; Pageot N; Taieb G; Camu W
    Rev Neurol (Paris); 2017 May; 173(5):308-319. PubMed ID: 28456383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Established Stem Cell Model of Spinal Muscular Atrophy Is Applicable in the Evaluation of the Efficacy of Thyrotropin-Releasing Hormone Analog.
    Ohuchi K; Funato M; Kato Z; Seki J; Kawase C; Tamai Y; Ono Y; Nagahara Y; Noda Y; Kameyama T; Ando S; Tsuruma K; Shimazawa M; Hara H; Kaneko H
    Stem Cells Transl Med; 2016 Feb; 5(2):152-63. PubMed ID: 26683872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One Year of Newborn Screening for SMA - Results of a German Pilot Project.
    Vill K; Kölbel H; Schwartz O; Blaschek A; Olgemöller B; Harms E; Burggraf S; Röschinger W; Durner J; Gläser D; Nennstiel U; Wirth B; Schara U; Jensen B; Becker M; Hohenfellner K; Müller-Felber W
    J Neuromuscul Dis; 2019; 6(4):503-515. PubMed ID: 31594245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.